Clinical trial
A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active…
NCT00109408 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00109408 |
|---|---|
| Title | A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis |
| Official title | A Randomized, Double-blind Study of Safety and Reduction in Signs and Symptoms During Treatment With Tocilizumab Monotherapy Versus Methotrexate Monotherapy in Patients With Moderate to Severe Active Rheumatoid Arthritis |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | Methotrexate, tocilizumab [RoActemra/Actemra] |
| Enrollment | 673 |
| Start date | Jul 1, 2005 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Apr 28, 2005 |
| Last update posted | Nov 2, 2016 |
| Countries | Argentina, Australia, Canada, China, Denmark, France, Israel, Italy, Lithuania, Mexico, Norway, Peru and 6 more |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: